{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:53:42Z","timestamp":1768272822826,"version":"3.49.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.clon.2014.03.005","type":"journal-article","created":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T14:33:11Z","timestamp":1404484391000},"page":"473-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Chemoradiotherapy for Squamous Cell Cancer of the Anal Canal: A Systematic Review"],"prefix":"10.1016","volume":"26","author":[{"given":"K.","family":"Spithoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Jonker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Biagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2014.03.005_bib1","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM200003163421107","article-title":"Carcinoma of the anal canal","volume":"342","author":"Ryan","year":"2000","journal-title":"N\u00a0Eng J Med"},{"key":"10.1016\/j.clon.2014.03.005_bib2","series-title":"Cancer incidence in Canada 2004 to 2005","author":"Statistics Canada","year":"2007"},{"key":"10.1016\/j.clon.2014.03.005_bib3","series-title":"SEER cancer statistics review, 1975-2003","first-page":"1","author":"Ries","year":"2005"},{"key":"10.1016\/j.clon.2014.03.005_bib4","series-title":"Pathology and genetics of the digestive system","first-page":"145","article-title":"Tumours of the anal canal","author":"Fenger","year":"2000"},{"key":"10.1016\/j.clon.2014.03.005_bib5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1634\/theoncologist.12-5-524","article-title":"Anal cancer: an overview","volume":"12","author":"Uronis","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.clon.2014.03.005_bib6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s10350-004-0934-z","article-title":"Management of anal canal carcinoma","volume":"48","author":"Sato","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clon.2014.03.005_bib7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02586980","article-title":"Combined therapy for cancer of the anal canal: a preliminary report","volume":"17","author":"Nigro","year":"1974","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"10.1016\/j.clon.2014.03.005_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF02586784","article-title":"Combined treatment of squamous cell carcinoma of the anal canal: radical radiation therapy with 5-fluorouracil and mitomycin C. A preliminary report","volume":"23","author":"Cummings","year":"1980","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clon.2014.03.005_bib9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/BF02553933","article-title":"An evaluation of combined therapy for squamous cell cancer of the anal canal","volume":"27","author":"Nigro","year":"1984","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clon.2014.03.005_bib10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1200\/JCO.1995.13.2.502","article-title":"The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation","volume":"13","author":"Browman","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2014.03.005_bib11","unstructured":"Spithoff K, Cummings B, Jonker D, et\u00a0al. Management of squamous cell cancer of the anal canal. Available at: http:\/\/www.cancercare.on.ca\/toolbox\/qualityguidelines\/diseasesite\/gastro-ebs\/."},{"key":"10.1016\/j.clon.2014.03.005_bib12","series-title":"Cochrane handbook for systematic reviews of interventions","year":"2008"},{"key":"10.1016\/j.clon.2014.03.005_bib13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2014.03.005_bib14","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2014.03.005_bib15","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized Intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2014.03.005_bib16","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.clon.2014.03.005_bib17","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","article-title":"Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 Trial","volume":"30","author":"Peiffert","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2014.03.005_bib18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2x2 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2014.03.005_bib19","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomized UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2014.03.005_bib20","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI Intergroup 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.clon.2014.03.005_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.radonc.2007.12.004","article-title":"Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD 03)","volume":"87","author":"Tournier-Rangeard","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2014.03.005_bib22","series-title":"TNM: classification of malignant tumours","year":"1987"},{"key":"10.1016\/j.clon.2014.03.005_bib23","series-title":"TNM: classification of malignant tumours","year":"1978"},{"key":"10.1016\/j.clon.2014.03.005_bib24","series-title":"AJCC manual for staging of cancer","year":"1988"},{"key":"10.1016\/j.clon.2014.03.005_bib25","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/(SICI)1097-0142(19970815)80:4<805::AID-CNCR20>3.0.CO;2-W","article-title":"The National Cancer Data Base report on carcinoma of the anus","volume":"80","author":"Myerson","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2014.03.005_bib26","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ctrv.2011.02.003","article-title":"Chemotherapy\/chemoradiation in anal cancer: a systematic review","volume":"37","author":"Lim","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clon.2014.03.005_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/1097-0142(19840701)54:1<114::AID-CNCR2820540124>3.0.CO;2-P","article-title":"Carcinoma of the anal canal. A clinical and pathologic study of 188 cases","volume":"54","author":"Boman","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2014.03.005_bib28","first-page":"509","article-title":"Treatment of epidermoid carcinoma of the anal canal","volume":"161","author":"Greenall","year":"1985","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.clon.2014.03.005_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ijrobp.2007.06.072","article-title":"Involved-field, low-dose chemoradiotherapy for early-stage anal carcinoma","volume":"70","author":"Hatfield","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2014.03.005_bib30","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0360-3016(89)90519-1","article-title":"Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases","volume":"17","author":"Schlienger","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2014.03.005_bib31","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/1097-0142(19940315)73:6<1569::AID-CNCR2820730607>3.0.CO;2-F","article-title":"Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients","volume":"73","author":"Touboul","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2014.03.005_bib32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0360-3016(96)00493-2","article-title":"Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications","volume":"37","author":"Peiffert","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2014.03.005_bib33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0360-3016(97)00814-6","article-title":"Interstitial iridium-192 implantation combined with external radiotherapy in anal cancer: ten years experience","volume":"40","author":"Sandhu","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2014.03.005_bib34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijrobp.2004.09.060","article-title":"Anal canal carcinoma: early-stage tumors < or = 10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy","volume":"62","author":"Ortholan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2014.03.005_bib35","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0360-3016(03)00417-6","article-title":"Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal","volume":"56","author":"Deniaud-Alexandre","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2014.03.005_bib36","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2010.29.1351","article-title":"Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11","volume":"28","author":"Ben-Josef","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2014.03.005_bib37","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.ijrobp.2010.07.1995","article-title":"\u201cMind the gap\u201d\u2014The impact of variations in the duration of the treatment gap and overall treatment time in the first UK Anal Cancer Trial (ACT 1)","volume":"81","author":"Glynne-Jones","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2014.03.005_bib38","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/02841860600726729","article-title":"Chemoradiotherapy in patients with anal cancer: impact of length of unplanned treatment interruption on outcome","volume":"45","author":"Meyer","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clon.2014.03.005_bib39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.brachy.2007.02.152","article-title":"Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma","volume":"6","author":"Oehler-Janne","year":"2007","journal-title":"Brachytherapy"},{"key":"10.1016\/j.clon.2014.03.005_bib40","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1200\/JCO.2007.12.0170","article-title":"Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicentre experience","volume":"25","author":"Salama","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"S","key":"10.1016\/j.clon.2014.03.005_bib41","article-title":"Elective clinical target volumes for conformal therapy in anorectal cancer: an RTOG Consensus Panel Contouring Atlas","volume":"72","author":"Myerson","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2014.03.005_bib42","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.ijrobp.2006.11.038","article-title":"Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy","volume":"67","author":"Vuong","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2014.03.005_bib43","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/(SICI)1097-0142(19990415)85:8<1686::AID-CNCR7>3.0.CO;2-7","article-title":"Malignant tumors of the anal canal: the spectrum of disease, treatment and outcomes","volume":"85","author":"Klas","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2014.03.005_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jso.20054","article-title":"Squamous cell carcinoma of the anal margin","volume":"86","author":"Newlin","year":"2004","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.clon.2014.03.005_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/028418601750071019","article-title":"Sphincter-conserving treatment\u00a0of\u00a0carcinomas of the anal margin","volume":"40","author":"Bieri","year":"2001","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.clon.2014.03.005_bib46","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1200\/JCO.2007.14.2810","article-title":"Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era","volume":"26","author":"Chiao","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.clon.2014.03.005_bib47","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1080\/003655200750056682","article-title":"Anal carcinoma: a 15-year retrospective analysis","volume":"35","author":"Olofinlade","year":"2000","journal-title":"Scand J Gastroent"},{"key":"10.1016\/j.clon.2014.03.005_bib48","series-title":"HIV-positive (+) patients on HAART treated with chemoradiation for squamous cell carcinoma of the anus: efficacy and toxicity compared with HIV-negative (-) patients","author":"Cohen","year":"2008"},{"issue":"10","key":"10.1016\/j.clon.2014.03.005_bib49","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/BF02234605","article-title":"HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients","volume":"44","author":"Kim","year":"2001","journal-title":"Dis Colon Rectum"},{"issue":"15","key":"10.1016\/j.clon.2014.03.005_bib50","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1200\/JCO.2007.15.2348","article-title":"HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy","volume":"26","author":"Oehler-Janne","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"18S","key":"10.1016\/j.clon.2014.03.005_bib51","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1200\/jco.2007.25.18_suppl.4632","article-title":"Comparison of squamous cell carcinoma of the canal anal (SCCA) prognosis in patients infection or not by human immunodeficiency virus (HIV) [abstract]","volume":"25","author":"Mathieu","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.clon.2014.03.005_bib52","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/aje\/kwm017","article-title":"The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS","volume":"165","author":"Hessol","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.clon.2014.03.005_bib53","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/00126334-200412150-00004","article-title":"HIV-associated anal cancer: has highly active anti-retroviral therapy reduced the incidence or improved the outcome?","volume":"37","author":"Bower","year":"2004","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.clon.2014.03.005_bib54","series-title":"Is chemoradiation the treatment of choice for anal squamous cell carcinoma developing in HIV-positive patients with access to highly active antiretroviral therapy? [abstract]","author":"Allen-Mersh","year":"2004"},{"issue":"1","key":"10.1016\/j.clon.2014.03.005_bib55","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijrobp.2006.03.049","article-title":"Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities","volume":"66","author":"Edelman","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"18S","key":"10.1016\/j.clon.2014.03.005_bib56","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1200\/jco.2006.24.18_suppl.4154","article-title":"Treatment of HIV positive anal cancer patients with chemoradiation [abstract]","volume":"24","author":"Hwang","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2014.03.005_bib57","series-title":"Treatment of anal carcinoma in HIV-positive males: a single institution experience [abstract]","author":"Parthasarathy","year":"2006"},{"issue":"6","key":"10.1016\/j.clon.2014.03.005_bib58","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0959-8049(00)00009-5","article-title":"Treatment of HIV-associated invasive anal cancer with combined chemoradiation","volume":"36","author":"Cleator","year":"2000","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.clon.2014.03.005_bib59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10350-007-9154-7","article-title":"Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcomes in the era of highly active antiretroviral therapy","volume":"51","author":"Wexler","year":"2008","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.clon.2014.03.005_bib60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0360-3016(98)00528-8","article-title":"The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer","volume":"44","author":"Hoffman","year":"1999","journal-title":"Int J Rad Oncol Bio Phys"},{"issue":"4","key":"10.1016\/j.clon.2014.03.005_bib61","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2036.2009.04026.x","article-title":"Epidermoid anal cancer prognosis comparison among HIV+ and HIV- patients","volume":"30","author":"Abramowitz","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.clon.2014.03.005_bib62","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/DCR.0b013e31819eefa6","article-title":"HIV and anal cancer outcomes: a single institution's experience","volume":"52","author":"Hogg","year":"2009","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.clon.2014.03.005_bib63","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijrobp.2008.10.046","article-title":"Outcomes of chemoradiotherapy with 5-fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients","volume":"75","author":"Seo","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clon.2014.03.005_bib64","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.ijrobp.2009.03.060","article-title":"Concurrent Chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy","volume":"76","author":"Fraunholz","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.clon.2014.03.005_bib65","first-page":"238","article-title":"Efficacy and toxicity of chemoradiation in the treatment of HIV-associated anal cancer","volume":"9","author":"Hauerstock","year":"2010","journal-title":"Clin Colorectal Cancer"},{"issue":"1","key":"10.1016\/j.clon.2014.03.005_bib66","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.radonc.2010.11.011","article-title":"Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for anal carcinoma: are there differences between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy?","volume":"98","author":"Fraunholz","year":"2011","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.clon.2014.03.005_bib67","first-page":"135","article-title":"Squamous cell cancer of the anal canal in HIV-infected patients receiving highly active antiretroviral therapy: a single institution experience","volume":"34","author":"Hammad","year":"2011","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clon.2014.03.005_bib68","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/DCR.0b013e3182137de9","article-title":"Anal carcinoma in HIV-infected patients in the era of antiretroviral therapy: a comparative study","volume":"54","author":"Munoz-Bongrand","year":"2011","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.clon.2014.03.005_bib69","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/annonc\/mdr050","article-title":"Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppression","volume":"23","author":"Alfa-Wali","year":"2012","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.clon.2014.03.005_bib70","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1258\/ijsa.2011.011020","article-title":"Evaluation of the impact of HIV serostatus, tobacco smoking and CD4 counts on epidermoid anal cancer survival","volume":"23","author":"Linam","year":"2012","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.clon.2014.03.005_bib71","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1245\/s10434-006-9221-7","article-title":"Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal","volume":"14","author":"Mullen","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clon.2014.03.005_bib72","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/BF02237294","article-title":"Results of salvage abdominoperineal resection for anal cancer after radiotherapy","volume":"41","author":"Pocard","year":"1998","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clon.2014.03.005_bib73","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<405::AID-CNCR7>3.0.CO;2-Q","article-title":"Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment","volume":"86","author":"Allal","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2014.03.005_bib74","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00000658-199407000-00007","article-title":"Recurrent squamous cell carcinoma of the anal canal. Predictions of initial treatment failure and results of salvage therapy","volume":"220","author":"Longo","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.clon.2014.03.005_bib75","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1245\/s10434-007-9491-8","article-title":"Outcomes of salvage surgery for squamous cell carcinoma of the anal canal","volume":"14","author":"Schiller","year":"2007","journal-title":"Ann Surg Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655514000880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655514000880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:39:53Z","timestamp":1760542793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655514000880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":75,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0936655514000880"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2014.03.005","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemoradiotherapy for Squamous Cell Cancer of the Anal Canal: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2014.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}